Lynn Seely
CIK 1327111 · President and CEO · last filed 2026-08-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.16M
Companies
6
Total Filings
74
Lifetime Open-Market Net
-$37.72M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LYEL | President and CEO | 73,488 | $13.55 | $995.8K | -$182.7K | 14 | 2026-08-11 |
| ABCL | Director | — | $11.20 | — | $0 | 1 | 2026-07-06 |
| Blueprint Medicines Corp (BPMC) Delisted | Director | 13,254 | $129.46 | $1.72M | $0 | 13 | 2025-07-21 |
| Myovant Sciences Ltd. (MYOV) Delisted | Principal Executive Officer | 1,889,992 | $26.98 | $50.99M | $0 | 5 | 2020-04-07 |
| MEDIVATION, INC. (MDVN) Delisted | Chief Medical Officer | 193,388 | — | — | -$37.38M | 40 | 2015-02-18 |
| MDV | Chief Medical Officer | 9,000 | $18.05 | $162.4K | -$160.2K | 1 | 2007-03-20 |
Recent Filings · Page 6 of 8
74 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-05-24 | MEDIVATION, INC. (MDVN) Delisted | Mixed | — | -$938.0K | EDGAR |
| 2012-05-21 | MEDIVATION, INC. (MDVN) Delisted | Mixed | — | -$959.8K | EDGAR |
| 2012-05-16 | MEDIVATION, INC. (MDVN) Delisted | Mixed | — | -$2.38M | EDGAR |
| 2012-03-12 | MEDIVATION, INC. (MDVN) Delisted | Mixed | −5,555 | -$6.95M | EDGAR |
| 2011-12-13 | MEDIVATION, INC. (MDVN) Delisted | Grant (A) | +10,400 | $0 | EDGAR |
| 2011-03-17 | MEDIVATION, INC. (MDVN) Delisted | Mixed | — | -$643.9K | EDGAR |
| 2011-02-16 | MEDIVATION, INC. (MDVN) Delisted | Mixed | — | -$718.3K | EDGAR |
| 2011-01-20 | MEDIVATION, INC. (MDVN) Delisted | Mixed | — | -$571.0K | EDGAR |
| 2010-12-17 | MEDIVATION, INC. (MDVN) Delisted | Grant (A) | +16,666 | $0 | EDGAR |
| 2009-12-17 | MEDIVATION, INC. (MDVN) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.